KCT0007408
Not yet recruiting
未知
Tailored versus Conventional Antiplatelet Strategy intended After Optimized Drug Eluting Stent
ConditionsDiseases of the circulatory system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the circulatory system
- Sponsor
- Asan Medical Center
- Enrollment
- 3944
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Men or women \=18 years
- •2\) Typical chest pain or objective evidence of myocardial ischemia suitable for PCI
- •3\) Significant de novo coronary artery lesions suitable for DES implantation
- •4\) Patients who underwent optimized stent implantation either by IVUS or OCT
- •5\) The patient or guardian agrees to the study protocol and the schedule of clinical follow\-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethical Committee of the respective clinical site
Exclusion Criteria
- •1\) Angiographic exclusion criteria: any of the followings
- •1\. Bypass graft lesions
- •2\. Lesions in which impaired delivery of imaging catheters is expected:
- •\- Extreme angulation (\=90°) proximal to or within the target lesion.
- •\- Excessive tortuosity (\= two 45° angles) proximal to or within the target lesion.
- •\- Heavy calcification proximal to or within the target lesion.
- •2\) In\-stent restenosis
- •3\) Hypersensitivity or contraindication to device material and its degradants and cobalt, chromium, nickel, platinum, tungsten, acrylic and fluoro polymers that cannot be adequately pre\-medicated.
- •4\) Persistent thrombocytopenia (platelet count \<80,000/l)
- •5\) Any history of hemorrhagic stroke or intracranial hemorrhage / TIA or ischemic stroke within the past 6 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Effect and safety of tailored antiplatelet therapy based on platelet function testing in coil embolization for unruptured aneurysmKCT0005550Bundang Jesaeng Hospital1,780
Completed
Not Applicable
Controlled Anti-platelet medical therapy based on rapid CYP2C19 gene evaluation in Acute myocardial infarctioAcute myocardial infarctionJPRN-UMIN000008151Graduate School of Medical Sciences, Kumamoto University100
Recruiting
Not Applicable
Comparison of Tailored Antiplatelet Therapy With Early Escalation and Late DeEscalation Strategy versus Standard Dual Antiplatelet Therapy in Patients Undergoing Complex High-Risk Percutaneous Coronary InterventioDiseases of the circulatory systemKCT0002917Asan Medical Center2,000
Recruiting
Phase 4
Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting StentCoronary Artery DiseaseNCT05418556Asan Medical Center3,944
Recruiting
Not Applicable
Dual-AntiPlatelet Therapy strategies FOR elective PCI in a REAL-world settingNL-OMON51842Amsterdam UMC1,462